Data is not available at this time.
Ventas, Inc. is a leading real estate investment trust (REIT) specializing in healthcare properties, including senior housing communities, medical office buildings, and life science facilities. The company operates through a diversified portfolio that generates stable cash flows from long-term leases and management agreements. Ventas capitalizes on demographic trends, such as an aging population and increasing healthcare demand, positioning itself as a key player in the healthcare real estate sector. Its revenue model combines rental income from tenants with growth opportunities through strategic acquisitions and development projects. The company’s market position is strengthened by partnerships with top-tier healthcare operators, ensuring high occupancy rates and sustainable returns. Ventas differentiates itself through scale, operational expertise, and a focus on high-quality assets in attractive markets, making it a preferred choice for investors seeking exposure to healthcare real estate.
Ventas reported revenue of $4.92 billion for the period, with net income of $81.2 million and diluted EPS of $0.19. Operating cash flow stood at $1.33 billion, reflecting strong cash generation from its property portfolio. Capital expenditures totaled $603.8 million, indicating ongoing investments in property maintenance and development. The company’s ability to convert revenue into cash flow underscores its operational efficiency and disciplined cost management.
Ventas demonstrates solid earnings power, supported by its diversified healthcare property portfolio. The company’s capital efficiency is evident in its ability to generate substantial operating cash flow relative to its revenue. With $897.9 million in cash and equivalents, Ventas maintains liquidity to fund growth initiatives while managing its $13.7 billion debt load. The balance between earnings and capital deployment highlights its strategic focus on sustainable growth.
Ventas’s balance sheet reflects a robust yet leveraged position, with total debt of $13.7 billion offset by $897.9 million in cash and equivalents. The company’s financial health is supported by its ability to generate consistent cash flow, which aids in servicing debt and funding dividends. Its REIT structure necessitates a focus on maintaining liquidity and prudent leverage ratios to sustain dividend payments and growth investments.
Ventas has maintained a dividend per share of $1.80, appealing to income-focused investors. Growth trends are driven by demographic tailwinds in healthcare demand and strategic property acquisitions. The company’s focus on high-quality assets and operator partnerships positions it for long-term growth, though near-term performance may be influenced by macroeconomic conditions and healthcare sector dynamics.
Ventas’s valuation reflects its position as a leading healthcare REIT, with market expectations centered on its ability to sustain cash flow growth and dividend payments. The company’s diversified portfolio and demographic advantages provide a foundation for stable performance, though investor sentiment may fluctuate with interest rate movements and sector-specific trends.
Ventas benefits from strategic advantages, including a diversified healthcare property portfolio and strong operator relationships. The outlook remains positive, supported by long-term demographic trends and the company’s disciplined capital allocation. Challenges include managing leverage and navigating sector-specific risks, but Ventas is well-positioned to capitalize on growth opportunities in the healthcare real estate market.
Company filings, investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |